Global Cytotoxic Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cytotoxic Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.
Cytotoxic drugs can prevent the rapid growth and division of cancer cells. They can also affect the growth of other quick dividing cells in the body, like hair follicles and the lining of the digestive system. As a result of the treatment, many normal cells are damaged along with the cancer cells.
Cytotoxic Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cytotoxic Drug market is projected to reach US$ 15860 million in 2034, increasing from US$ 14680 million in 2022, with the CAGR of 1.1% during the period of 2024 to 2034. Demand from Breast Cancer and Blood Cancer are the major drivers for the industry.
Market competition is intense. Roche, Eli Lilly, Celgene, Sanofi, eisai, Sumitomo Dainippon Pharma, Merck, Seattle Genetics and Takeda, etc. are the leaders of the industry, with about 63% market shares.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection is about 94%.
Cytotoxic Drug is widely used in Breast Cancer, Blood Cancer, Prostate Cancer, Respiratory/Lung Cancer and other diseases. The most proportion of Cytotoxic Drug is for other diseases, and the consumption proportion for blood cancer is about 24%.
USA region is the largest supplier of Cytotoxic Drug, with a production market share nearly 44%. Europe is the second largest supplier of Cytotoxic Drug, enjoying production market share nearly 31%.
North America is the largest consumption place, with a consumption market share nearly 38%. Following North America, Europe is the second largest consumption place with the consumption market share of 32%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cytotoxic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
Segment by Type
Injection
Solid Oral Dose Forms
Others
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cytotoxic Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cytotoxic Drug introduction, etc. Cytotoxic Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cytotoxic Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Cytotoxic drugs can prevent the rapid growth and division of cancer cells. They can also affect the growth of other quick dividing cells in the body, like hair follicles and the lining of the digestive system. As a result of the treatment, many normal cells are damaged along with the cancer cells.
Cytotoxic Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cytotoxic Drug market is projected to reach US$ 15860 million in 2034, increasing from US$ 14680 million in 2022, with the CAGR of 1.1% during the period of 2024 to 2034. Demand from Breast Cancer and Blood Cancer are the major drivers for the industry.
Market competition is intense. Roche, Eli Lilly, Celgene, Sanofi, eisai, Sumitomo Dainippon Pharma, Merck, Seattle Genetics and Takeda, etc. are the leaders of the industry, with about 63% market shares.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection is about 94%.
Cytotoxic Drug is widely used in Breast Cancer, Blood Cancer, Prostate Cancer, Respiratory/Lung Cancer and other diseases. The most proportion of Cytotoxic Drug is for other diseases, and the consumption proportion for blood cancer is about 24%.
USA region is the largest supplier of Cytotoxic Drug, with a production market share nearly 44%. Europe is the second largest supplier of Cytotoxic Drug, enjoying production market share nearly 31%.
North America is the largest consumption place, with a consumption market share nearly 38%. Following North America, Europe is the second largest consumption place with the consumption market share of 32%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cytotoxic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
Segment by Type
Injection
Solid Oral Dose Forms
Others
Segment by Application
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cytotoxic Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cytotoxic Drug introduction, etc. Cytotoxic Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cytotoxic Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices